Navigation Links
China Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on February 18, 2011
Date:12/16/2010

HONG KONG, Dec. 16, 2010 /PRNewswire-Asia-FirstCall/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or "the Company"), the first and largest cord blood banking operator in China, today announced that the Company will hold its annual general meeting of record at the Company's Hong Kong office at 48/F, Bank of China Tower, 1 Garden Road, Central, Hong Kong, at 9:00 p.m. on February 18, 2011 Hong Kong Time (February 18, 2011 8:00 a.m. U.S. Eastern Time).  The shareholder record date is January 12, 2011.

China Cord Blood Corporation filed its annual report on Form 20-F, including its audited financial statements for the fiscal year ended March 31, 2010, with the U.S. Securities and Exchange Commission (the "SEC") on July 16, 2010, and filed an amendment to its annual report on Form 20-F/A with the SEC on October 20, 2010.  CCBC's annual report on Form 20-F and the amendment to the annual report on Form 20-F/A can be accessed at the Investor Center section of the Company's website at http://www.chinacordbloodcorp.com, as well as on the SEC's website at http://www.sec.gov.  Shareholders may request a hard copy of the complete and audited financial statements on Form 20-F free of charge, by contacting ir@chinacordbloodcorp.com.

About China Cord Blood CorporationChina Cord Blood Corporation is the first and largest cord blood banking operator in China in terms of geographical coverage and is the only cord blood banking operator with multiple licenses.  Under the current PRC government regulations, only one licensed cord blood banking operator is permitted to operate in each licensed region and only seven licenses have been authorized as of today.  China Cord Blood Corporation provides cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services.  For more information, please visit our website at http://www.chinacordbloodcorp.com.  

Safe Harbor Statement This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events, performance and results of operations, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in statements filed from time to time with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the Company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof. For more information, please contact:China Cord Blood CorporationMs. Joeling LawTel:   +852 3605 8180Email: ir@chinacordbloodcorp.com ICR, LLCIn New York: Ashley M. Ammon: +1-646-277-1227In Beijing: Wen Lei Zheng: +86-10-6583-7510
'/>"/>

SOURCE China Cord Blood Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. China-Biotics, Inc. to Hold 2010 Annual Meeting of Stockholders on March 9, 2011
2. China Cord Blood Corporation Announces Completion of Warrant Exchange
3. China-Biotics Announces Redemption of $25 million in Senior Convertible Notes
4. China Cord Blood Corporation Announces Participation at the 29th Annual J.P. Morgan Healthcare Conference
5. PRA International Expert to Speak at China Drug Safety Summit
6. Tianyins Dr. James Jiayuan Tong is Invited to Speak at the CFO China Summit 2011 on January 19, 2011 at the St. Regis Hotel, Beijing
7. China Biologic Products to Present at Brean Murray, Carret 2010 China Growth Conference
8. China-Biotics Appoints New Chief Operating Officer
9. China Biologic Products Schedules Conference Call to Discuss Third Quarter 2010 Results
10. China-Biotics to Report Fiscal Year 2011 Second Quarter Financial Results on November 9
11. Verenium Announces Regulatory Approval for Purifine® PLC in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... 19, 2017 , ... November Research Group, LLC, a global ... device manufacturers and regulators, is proud to announce the worldwide release of PRIMO ... to provide product vigilance departments with the flexibility and ease of use of ...
(Date:1/19/2017)... ... January 18, 2017 , ... The American Medical ... update its Data Sharing Policy. Specifically, the nation’s leading informatics experts, said data ... the existing policy. AMIA recommended that NIH earmark funding for researchers to produce ...
(Date:1/19/2017)... The global biotechnology services outsourcing market ... 2025, according to a new report by Grand ... of the function of outsourcing certain clinical and ... services outsourced, clinical trial management and contract manufacturing ... was the first pharmaceutical company to outsource its ...
(Date:1/18/2017)... ... 2017 , ... Opal Kelly, a leading producer of powerful ... the ZEM5310 USB 3.0 FPGA Module, combining a SuperSpeed USB 3.0 interface and ... suitable for prototyping, testing, and production-ready integration. The ZEM5310 USB interface delivers real-world ...
Breaking Biology Technology:
(Date:12/15/2016)... Germany , December 15, 2016 ... announced an agreement with NuData Security, an award-winning ... partnership will enable clients to focus on good customer experience, ... protection regulation. ... In order to provide a one-stop fraud prevention suite, ...
(Date:12/15/2016)... -- "Increase in mobile transactions is driving the growth ... is expected to grow from USD 4.03 billion in ... CAGR of 29.3% between 2016 and 2022. The market ... for smart devices, government initiatives, and increasing penetration of ... expected to grow at a high rate during the ...
(Date:12/7/2016)... Israel , December 7, 2016 BioCatch ... the expansion of its patent portfolio, which grew to over 40 granted ... , , ... its recently filed patent entitled " System, Device, and Method ... technology that enables device makers to forego costly hardware components needed to ...
Breaking Biology News(10 mins):